Acute normal tissue tolerance to 7 day per week accelerated fractionation.
Fifty-six sites in 49 patients were irradiated by a 7 day/week accelerated fractionation schedule to conventional tumor doses. Daily doses were 180 to 200 rad in 85% of sites. Patients were analyzed for normal tissue tolerance. A 7 day/week accelerated fractionation appears clinically tolerable at 180 rad per fraction.
D004064:Digestive System / Q000528:radiation effects; D004941:Esophagitis / Q000209:etiology; D006801:Humans; D009092:Mucous Membrane / Q000528:radiation effects; D009369:Neoplasms / Q000532:radiotherapy*; D011836:Radiation Tolerance; D011855:Radiodermatitis / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects*; D011879:Radiotherapy Dosage